• OPEN AN ACCOUNT
Indian Indices
Nifty
24,379.60 -81.55
(-0.33%)
Sensex
80,641.07 -155.77
( -0.19%)
Bank Nifty
54,271.40 -648.10
( -1.18%)
Nifty IT
35,869.20 -122.05
( -0.34%)
Global Indices
Nasdaq
41,230.34 -108.09
(-0.26%)
Dow Jones
5,669.98 -37.69
(-0.66%)
Hang Seng
36,831.70 379.40
(1.04%)
Nikkei 225
8,597.42 1.07
(0.01%)
Forex
USD-INR
84.57 -0.05
(-0.06%)
EUR-INR
95.56 -0.09
(-0.09%)
GBP-INR
112.19 -0.34
(-0.31%)
JPY-INR
0.58 0.00
(-0.31%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
322.4611705
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
18.87
97839.89
EPS(TTM)
Face Value()
Div & Yield %
62.12
1
0.68
 

tci finance ltd
Jindal Saw consolidated net profit declines 42.00% in the March 2025 quarter
May 02,2025
Net profit of Jindal Saw declined 42.00% to Rs 291.28 crore in the quarter ended March 2025 as against Rs 502.18 crore during the previous quarter ended March 2024. Sales declined 6.98% to Rs 5046.59 crore in the quarter ended March 2025 as against Rs 5425.16 crore during the previous quarter ended March 2024.

For the full year,net profit rose 3.66% to Rs 1738.37 crore in the year ended March 2025 as against Rs 1677.03 crore during the previous year ended March 2024. Sales declined 0.61% to Rs 20828.89 crore in the year ended March 2025 as against Rs 20957.69 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales5046.595425.16 -7 20828.8920957.69 -1
OPM %14.5916.96 -16.4615.84 -
PBDT625.13815.12 -23 2951.022783.66 6
PBT472.51666.51 -29 2348.962215.67 6
NP291.28502.18 -42 1738.371677.03 4